BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29402500)

  • 1. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
    Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
    Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model.
    Warias A; Ferguson M; Chamberlain E; Currie L; Snow N; Matheson K; Penney LS; Kieser K
    J Genet Couns; 2021 Oct; 30(5):1491-1499. PubMed ID: 33876505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
    Petzel SV; Vogel RI; Bensend T; Leininger A; Argenta PA; Geller MA
    J Genet Couns; 2013 Oct; 22(5):662-73. PubMed ID: 23677535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
    Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
    Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
    Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
    Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
    Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
    Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
    Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
    Bednar EM; Oakley HD; Sun CC; Burke CC; Munsell MF; Westin SN; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):399-404. PubMed ID: 28610746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
    Armel SR; Volenik A; Demsky R; Malcolmson J; Maganti M; McCuaig J
    Gynecol Oncol; 2020 Aug; 158(2):440-445. PubMed ID: 32505554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
    Helpman L; Zidan O; Friedman E; Kalfon S; Perri T; Ben-Baruch G; Korach J
    J Gynecol Oncol; 2017 Sep; 28(5):e61. PubMed ID: 28657222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
    Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
    JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
    Alimena S; Scarpetti L; Blouch EL; Rodgers L; Shannon K; Del Carmen M; Goodman A; Growdon WB; Eisenhauer E; Sisodia RC
    Int J Gynecol Cancer; 2020 Sep; 30(9):1397-1403. PubMed ID: 32447294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
    Boitano TKL; Barrington DA; Batra S; McGwin G; Turner TB; Farmer MB; Brown AM; Straughn MJ; Leath CA
    Gynecol Oncol; 2019 Aug; 154(2):379-382. PubMed ID: 31196574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
    Demsky R; McCuaig J; Maganti M; Murphy KJ; Rosen B; Armel SR
    Gynecol Oncol; 2013 Aug; 130(2):329-33. PubMed ID: 23707676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.